The evolving genomic landscape in urothelial cancer-Reference-Cited by-同舟云学术

The evolving genomic landscape in urothelial cancer

Published:2018-05 Issue:3 Volume:30 Page:197-202
ISSN:1040-8746
Container-title:Current Opinion in Oncology
language:en
Short-container-title:

Author:

Kujtan Lara,Hussain Arif,Subramanian Janakiraman,Masood Ashiq

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference24 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity;Knowles;Nat Rev Cancer,2015

3. The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate;van Rhijn;Cancer Res,2001

4. Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome;Lindgren;Cancer Res,2010

5. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group;Prout;J Urol,1992

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A deep‐learning workflow to predict upper tract urothelial carcinoma protein‐based subtypes from H&E slides supporting the prioritization of patients for molecular testing;The Journal of Pathology: Clinical Research;2024-03

2. Existing trends and applications of artificial intelligence in urothelial cancer;Canadian Urological Association Journal;2023-08-03

3. A deep-learning workflow to predict upper tract urothelial cancer subtypes supporting the prioritization of patients for molecular testing;2023-06-22

4. The targets of aspirin in bladder cancer: bioinformatics analysis;BMC Urology;2022-10-31

5. Current Knowledge on Genomic Profiling of Upper Tract Urothelial Carcinoma;Genes;2021-02-25